Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2023

Omvoh(Mirikizumab-Mrkz)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$1.1M

Medicare cost, 2024

Medicare drug plans spent $1.1 million on Omvoh (mirikizumab-mrkz) in 2024, for 107 prescriptions and refills filled by 42 patients. It was first approved in 2023. At about $10,439 per prescription it is a high-cost drug.

Medicare cost, 2024

$1.1M

Prescriptions

107

$10,438.58 per claim

Patients

42

40 prescribers

Total spending

-

All plans

Questions and answers

How much does Medicare spend on Omvoh?

Medicare prescription drug plans paid $1.1M for Omvoh in 2024, for 107 prescriptions and refills to 42 patients. The average cost per claim was $10,438.58.

Which state spends the most on Omvoh?

New York had the highest Medicare cost for Omvoh in 2024: $121K for 11 claims.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Prescriber data by year

YearPrescribersClaimsPatientsCost
20244010742$1.1M

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
10
RxNorm concept IDs
2668391, 2668398, 2668405, 2668410, 2680728
Application numbers
BLA761279

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube